Eloxx Pharmaceuticals, Inc. (ELOX)
About Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing novel, small-molecule product candidates designed to modulate the ribosome and promote readthrough of premature stop codons induced by nonsense mutations (NMs) to enable the production of full-length proteins. The exaluren, the company's investigational drug product for the treatment of rare kidney diseases, and, through the collaboration with Almirall, S.A. (Almirall), ZKN-013 for the treatment of rare skin diseases.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$6.0M
- Total assets
- $5.3M
- Market cap
- $41.0M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $34.4M
- Operating income
- -$34.4M
- Income tax
- $0
- Net income
- -$36.1M
- EPS (basic)
- $-16.65
- EPS (diluted)
- $-16.65
Balance sheet
- Total assets
- $21.1M
- Current assets
- $20.1M
- Total liabilities
- $31.8M
- Current liabilities
- $23.1M
- Shareholders’ equity
- -$10.7M
Cash flow
- Operating cash flow
- -$31.8M
- Investing cash flow
- -$66.0K
- Financing cash flow
- $8.8M
- Net cash flow
- -$23.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $41.0M
- EPS (diluted)
- $-16.65
- Shares outstanding
- 2.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 11, 1998
Eloxx Pharmaceuticals, Inc. (ELOX) Stock Price
- Reported a net loss of $6.0M in FY2025.
- Trading 8% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Eloxx Pharmaceuticals, Inc..
Write a review
News about Eloxx Pharmaceuticals, Inc.
News & sentiment via Polygon.io
Eloxx Pharmaceuticals, Inc.: frequently asked questions
Is Eloxx Pharmaceuticals, Inc. an American company?
Eloxx Pharmaceuticals, Inc. is a US-based company headquartered in Arlington, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Eloxx Pharmaceuticals, Inc. headquartered?
Eloxx Pharmaceuticals, Inc. is headquartered in Arlington, Massachusetts, United States.
Is Eloxx Pharmaceuticals, Inc. publicly traded?
Yes — Eloxx Pharmaceuticals, Inc. is a publicly traded company. Its stock trades under the ticker symbol ELOX on the OTC.
What does Eloxx Pharmaceuticals, Inc. do?
Eloxx Pharmaceuticals, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
